Controlled Substance Monitoring and Drugs of Abuse Testing
J9 · Effective Oct 11, 2015
38 active Medicare policies list R40.20, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 11, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Jan 22, 2023
JM · Effective Jan 22, 2023
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J9 · Effective Oct 1, 2015
9 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of R40.20 |
|---|---|---|
| Attended Electroencephalographic (EEG) Video Monitoring | Apr 28, 2023 | Covered |
| Chest Physiotherapy and Airway Clearance Devices | Mar 17, 2023 | Covered |
| Cognitive Rehabilitation | Feb 9, 2024 | Covered |
| Intraoperative Neurophysiological Monitoring | Oct 26, 2023 | Covered |
| Lead Testing | Aug 9, 2023 | Covered |
| Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) of the Spine | Mar 29, 2023 | Covered |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 5, 2015
J6 · Effective Dec 24, 2023
JK · Effective Dec 24, 2023
JE · Effective Jun 28, 2016
JF · Effective Jun 28, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2024
National · Effective Oct 1, 2025
J6 · Effective Oct 1, 2020
National · Effective Oct 1, 2025
National · Effective Oct 23, 2025
National · Effective Oct 1, 2025
National · Effective Nov 1, 2024
J6 · Effective Oct 1, 2025
National · Effective Apr 16, 2026
National · Effective Jun 1, 2026
National · Effective Jun 1, 2026
National · Effective Apr 16, 2026
J5 · Effective Jun 1, 2026
J6 · Effective Nov 1, 2025
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
|---|
| Quantitative, Functional and Connectomic Analysis of Brain MRI | Oct 4, 2023 | Covered |
|---|
| Policy | Effective | Status of R40.20 |
|---|---|---|
| Electrodiagnostic Testing (EMG/NCV) | Sep 15, 2026 | Covered |